Isolated lung perfusion for the treatment of pulmonary metastases

Surgical Oncology

Volumn 7, Issue 1-2, 1998, Pages 59-63

  Hendriks, J M H ^a   Van Schil, P E Y ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Isolated lung perfusion; Lung metastases; Pulmonary metastasectomy

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN;

CANCER SURVIVAL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ISOLATED LUNG; LUNG METASTASIS; LUNG PERFUSION; LUNG RESECTION; PRIORITY JOURNAL; REGIONAL PERFUSION; REVIEW;

EID: 0032452261     PISSN: 09607404     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-7404(98)00028-0     Document Type: Short Survey

References (33)

1. [1] Crow J, Slavin G, Kreel L. Pulmonary metastases: a pathologic and radiologic study. Cancer 1981;47:2595-602.
2. [2] Divis G. Ein beitrag zur operativen behandlung der lungengeschwülste. Acta Chir Scand 1927;62:329-41.
3. [3] Carter SR, Grimer RJ, Sneath RS, Matthews HR. Results of thoracotomy in osteogenic sarcoma with pulmonary metastases. Thorax 1991;46:727-31.
4. [4] Thomford NR, Woolner LB, Clagett OT. The surgical treatment of metastatic tumors in the lungs. J Thorac Cardiovasc Surg 1965;49:357-63.
5. [5] Mc Cormack P. The surgical resection of pulmonary metastases. Semin Surg Oncol 1990;6:297-302.
6. [6] Pastorino U, Buyse M, Freidel G et al. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg 1997;113:37-49.
7. [7] Hendriks JMH, Van Schil PEY, Eyskens FJM. Pulmonary resection beyond pneumonectomy for lung metastases: report of two cases. Eur J Surg Oncol 1998; in press.
8. [8] Creech O Jr, Krementz E, Ryan R et al. Experiences with isolation-perfusion technics in the treatment of cancer. Ann Surg 1959;149:627.
9. [9] Krementz E. Regional perfusion: current sophistication, what next? Cancer 1986;57:416-32.
10. [10] Jacobs J, Flexner J, Scott H. Selective isolated perfusion of the right or left lung. J Thorac Cardiovasc Surg 1961;42:546.
11. [11] Pierpont H, Blades B. Lung perfusion with chemotherapeutic agents. J Thorac Cardiovasc Surg 1960;39:159-65.
12. [12] Johnston M, Minchin R, Shull J et al. Isolated lung perfusion with Adriamycin: a preclinical study. Cancer 1983;52:405-9.
13. [13] Miller B, Rosenbaum A. The vascular supply to metastatic tumors of the lung. Surg Gynecol Obstet 1967;125:1009-16.
14. [14] Baciewicz F, Arredondo M, Chaudhuri B et al. Pharmacokinetics and toxicity of isolated perfusion of lung with doxorubicin. J Surg Res 1991;50:124-8.
15. [15] Johnston M, Christensen C, Minchin R et al. Isolated total lung perfusion as a means to deliver organ-specific chemotherapy: long-term studies in animals. Surgery 1985;98:35-44.
16. [16] Johnston M, Minchin R, Dawson C. Lung perfusion with chemotherapy in patients with unresectable metastatic sarcoma to the lung or diffuse bronchioloalveolar carcinoma. J Thorac Cardiovasc Surg 1995;110:368-73.
17. [17] Ratto GB, Toma S, Civalleri D et al. Isolated lung perfusion with platinum in the treatment of pulmonary metastases from soft tissue sarcomas. J Thorac Cardiovasc Surg 1996;112:614-22.
18. [18] Weksler B, Schneider A, Ng B, Burt M. Isolated single-lung perfusion in the rat: an experimental model. J Appl Physiol 1993;74:2736-39.
19. [19] Hendriks JMH, Van Schil PEY. Modified technique of isolated left lung perfusion in the rat. Eur Surg Res 1998, in press.
20. [20] Abolhoda A, Brooks A, Nawata S, Kaneda Y, Cheng H, Burt ME. Isolated lung perfusion with doxorubicin prolongs survival in a rodent model of pulmonary metastases. Ann Thorac Surg 1997;64:181-4.
21. [21] Ansfield F, Klotz J, Nealon T et al. A phase II study comparing the clinical utility of four regimens of 5-fluorouracil. Cancer 1977;39:34-40.
22. [22] Ng B, Lenert J, Weksler B, Port J, Ellis J, Burt M. Isolated lung perfusion with FUDR is an effective treatment for colorectal adenocarcinoma lung metastases in rats. Ann Thorac Surg 1995;59:205-8.
23. [23] Nawata S, Abecasis N, Ross HM, Abolhoda A, Cheng H, Sachar K, Burt ME. Isolated lung perfusion with melphalan for the treatment of metastatic pulmonary sarcoma. J Thorac Cardiovasc Surg 1996;112:1542-8.
24. [24] Marinelli A, eds. Isolated liver perfusion. Treatment of hepatic metastases: experimental and clinical studies. 's Gravenhage: Pasmans offsetdrukkerij bv, 1992.
25. [25] Hendriks JMH, Van Schil PEY, Kuppen PJK et al. Isolated left lung perfusion with melphalan and tumor necrosis factor for metastatic pulmonary adenocarcinoma in the rat. Ann Thorac Surg 1998;66:1719-25.
26. [26] Havell EA, Fiers W, North RJ. The anti-tumor function of tumor necrosis factor (TNF). J Exp Med 1988;167:1067-85.
27. [27] Fraker DL, Alexander HR, Pass HI. Biological therapy with tumor necrosis factor: clinical applications by systemic and regional administration. In: V DeVlta, S Hellman and SA Rosenberg, eds. Biologic Therapy of Cancer, 2nd edition. Philadelphia: JB Lippincott, 1995:329-46.
28. [28] Alexander RB, Rosenberg SA. Tumor necrosis factor: clinical applications. In: DeVIta V, Hellman S, Rosenberg SA, editors. Biologic therapy of cancer. Philadelphia: JB Lippincott, 1991:378-92.
29. [29] Van der Schelling YGP, Ijzermans JNM, Kok TC. A phase I study of local treatment of liver metastases with recombinant tumor necrosis factor. Eur J Cancer 1992;28:1073-78.
30. [30] Lienard D, Ewalenko P, Delmotte JJ, Renard N, Lejeune FJ. High dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. J Clin Oncol 1992;10:52-60.
31. [31] Weksler B, Blumberg D, Lenert J, Ng B, Fong Y, Burt M. Isolated single-lung perfusion with TNF-alpha in a rat sarcoma lung metastases model. Ann Thorac Surg 1994;58:328-32.
32. [32] Pass HI, Mew DJ, Kranda KC, Temeck BK, Donington JS, Rosenberg SA. Isolated lung perfusion with tumor necrosis factor for pulmonary metastases. Ann Thorac Surg 1996;61: 1609-17.
33. [33] Furrer M, Lardinois D, Thormann W et al. Cytostatic lung perfusion by use of an endovascular blood flow occlusion technique. Ann Thorac Surg 1998;65:1523-8.